Literature DB >> 6539443

Internuclear ophthalmoplegia and "optic neuritis": paraneoplastic effects of bronchial carcinoma.

N Pillay, J J Gilbert, G C Ebers, J D Brown.   

Abstract

A 56-year-old man developed bilateral internuclear ophthalmoplegia and "optic neuritis" as remote effects of a bronchial carcinoma. These clinical findings correlated pathologically with secondary demyelination of the medial longitudinal fasciculus and with round cell infiltration and adhesive arachnoiditis of the optic nerve. There was no evidence of CNS metastasis. "Optic neuritis" and internuclear ophthalmoplegia may be paraneoplastic effects of systemic cancer.

Entities:  

Mesh:

Year:  1984        PMID: 6539443     DOI: 10.1212/wnl.34.6.788

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Anterior visual system involvement in non-Hodgkin's lymphoma.

Authors:  A G Zaman; E M Graham; M D Sanders
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

3.  Total extrinsic ophthalmoplegia as only paraneoplastic sign two years before X-ray diagnosis of bronchial carcinoma.

Authors:  F Barontini; S Maurri; P Marini
Journal:  Ital J Neurol Sci       Date:  1985-12

4.  CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.

Authors:  Masanori Nakajima; Ayumi Uchibori; Yuki Ogawa; Tai Miyazaki; Yaeko Ichikawa; Kimihiko Kaneko; Toshiyuki Takahashi; Ichiro Nakashima; Hirokazu Shiraishi; Masakatsu Motomura; Atsuro Chiba
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

5.  Optic Neuritis: A Rare Paraneoplastic Phenomenon of Hodgkin's Lymphoma.

Authors:  Yasir Khan; Waqas Khan; Nishanth Thalambedu; Ammar A Ashfaq; Waqas Ullah
Journal:  Cureus       Date:  2019-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.